Clinical Trial Update: T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum [Phase 3]

View source ↗

Summary

Phase 3 trial comparing T4N5 liposome lotion to placebo to prevent actinic keratoses in patients with xeroderma pigmentosum.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Xeroderma Pigmentosum

Drugs mentioned

• T4N5 Liposome Lotion

Snippet

Sponsor: Applied Genetics | Conditions: Precancerous Condition | Phase 3 | Status: UNKNOWN